Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Aledort

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Annals of Hematology|September 6, 2015
Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopeniaMarc Michel, Jeffrey Wasser, Bertrand Godeau, et al.
Journal of Immunological Methods|August 2, 2017
Application of phospho-CyTOF to characterize immune activation in patients with sickle cell disease in an ex vivo model of thrombosisJeffrey Glassberg, Adeeb H Rahman, Mohammad Zafar, et al.
Haematologica|December 1, 2020
Convalescent plasma for administration of passive antibodies against viral agentsGiovanni Di Minno, Pier Mannuccio Mannucci, James W Ironside, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 19, 2022
Are all licensed haemostatic agents for haemophilia therapy accessible to patients?Karin Berger, Angelika Batorova, Rhonda Bohn, et al.
Expert Review of Hematology|January 26, 2012
Managing incidentally diagnosed isolated factor VII deficiency perioperatively: a brief expert consensus reportSujit Sheth, Gerald Soff, Beau Mitchell, et al.
Neurocritical Care|July 20, 2016
The Role of Platelet Activation and Inflammation in Early Brain Injury Following Subarachnoid HemorrhageJennifer A Frontera, J Javier Provencio, Fatima A Sehba, et al.
Haematologica|November 14, 2024
Challenges associated with access to recently developed hemophilia treatments in routine care: perspectives of healthcare professionalsKarin Berger, Roxy H O'Rourke, Matteo Nicola Dario Di Minno, et al.
Haematologica|November 19, 2013
Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpuraSilvia Ferrari, Kristina Palavra, Bernadette Gruber, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of Hematology|September 6, 2015
Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopeniaMarc Michel, Jeffrey Wasser, Bertrand Godeau, et al.
Journal of Immunological Methods|August 2, 2017
Application of phospho-CyTOF to characterize immune activation in patients with sickle cell disease in an ex vivo model of thrombosisJeffrey Glassberg, Adeeb H Rahman, Mohammad Zafar, et al.
Haematologica|December 1, 2020
Convalescent plasma for administration of passive antibodies against viral agentsGiovanni Di Minno, Pier Mannuccio Mannucci, James W Ironside, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 19, 2022
Are all licensed haemostatic agents for haemophilia therapy accessible to patients?Karin Berger, Angelika Batorova, Rhonda Bohn, et al.
Expert Review of Hematology|January 26, 2012
Managing incidentally diagnosed isolated factor VII deficiency perioperatively: a brief expert consensus reportSujit Sheth, Gerald Soff, Beau Mitchell, et al.
Neurocritical Care|July 20, 2016
The Role of Platelet Activation and Inflammation in Early Brain Injury Following Subarachnoid HemorrhageJennifer A Frontera, J Javier Provencio, Fatima A Sehba, et al.
Haematologica|November 14, 2024
Challenges associated with access to recently developed hemophilia treatments in routine care: perspectives of healthcare professionalsKarin Berger, Roxy H O'Rourke, Matteo Nicola Dario Di Minno, et al.
Haematologica|November 19, 2013
Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpuraSilvia Ferrari, Kristina Palavra, Bernadette Gruber, et al.
Pageof 3